Cannabinoid type 1 receptor antagonism ameliorates harmaline‐induced essential tremor in rat

Abstract

These results provide the first evidence of the effects of modulating the endocannabinoid system on motor function in the harmaline model of ET. Our data suggest that CB₁ receptor manipulation warrants clinical investigation as a therapeutic approach to protection against behavioural disturbances associated with ET.